SEC Form 4 · accession 0001140361-17-003940
VASCULAR SOLUTIONS INC · VASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hennen
Officer — Sr. VP of Finance and CFO
Period of report
Jan 30, 2017
Accepted (ET)
Feb 1, 2017 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001030206
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 30, 2017 | F | 1,243 | $55.85 | D | 32,098 | D | |
| Common Stock | Jan 31, 2017 | F | 713 | $55.95 | D | 31,385 | D | |
| Common StockF1 | holding | — | — | — | 33,341 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Increase from last filing represents 53 shares acquired under the Vascular Solutions Stock Purchase Plan for the period ending October 31, 2016 at $29.62 per share.